Hypercalcemia and 13-cis-retinoic acid in post-consolidation therapy of neuroblastoma

Pediatric Blood and Cancer

Volumn 52, Issue 2, 2009, Pages 280-283

  Marabelle, Aurélien ^a   Sapin, Vincent ^b,c   Rousseau, Raphaël ^a,d   Periquet, Brigitte ^e   Demeocq, François ^b,c   Kanold, Justyna ^b,c  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INSERM   (France)

^d UNIVERSITÉ LYON 1   (France)

^e CHU RANGUEIL   (France)

Author keywords

13 cis retinoic acid; Hypercalcemia; Neuroblastoma

Indexed keywords

BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; ISOTRETINOIN; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE;

ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERCALCEMIA; MALE; NEUROBLASTOMA; OSTEOLYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT DURATION; BLOOD; CHEMICALLY INDUCED DISORDER; INFANT;

BONE RESORPTION; CALCIUM; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERCALCEMIA; INFANT; ISOTRETINOIN; MALE; NEUROBLASTOMA;

EID: 59449106716     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21768     Document Type: Article

References (19)

1. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's cancer group. N Engl J Med 1999;341:1165-1173.
2. Villablanca JG, Khan AA, Avramis VI, et al. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 1995;13:894-901.
3. Villablanca JG, Khan AA, Avramis VI, et al. Hypercalcemia: A dose-limiting toxicity associated with 13-cis-retinoic acid. Am J Pediatr Hematol Oncol 1993;15:410-415.
4. Valteau-Couanet D. Recommandations pour le traitement des enfants de plus de 1 an porteurs d'un neuroblastome stade 4. Société Française d'Oncologie Pédiatrique - Comité Neuroblastome 1999.
5. Armstrong JL, Redfern CPF, Veal GJ. 13-cis retinoic acid and isomerisation in paediatric oncology - Is changing shape the key to success? Biochem Pharmacol 2005;69:1299-1306.
6. Belden TL, Ragucci DP. Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma. Pharmacotherapy 2002;22:645-648.
7. Reynolds CP, Matthay KK, Villablanca JG, et al. Retinoid therapy of high-risk neuroblastoma. Cancer Lett 2003;197:185-192.
8. Reynolds CP, Lemons RS. Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am 2001;15:867-910.
9. Al-Rashid RA, Cress C. Hypercalcemia associated with neuroblastoma. Am J Dis Child 1979;133:838-841.
10. Nagasawa M, Okawa H. All-trans retinoic acid induced hypercalcemia in a patient with acute promyelocytic leukemia: Its relation to increased pth-rp. Int J Hematol 1994;59:143-144.
11. Niesvizky R, Siegel DS, Busquets X, et al. Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma. Br J Haematol 1995;89:217-218.
12. Olson JA. Adverse effects of large doses of vitamin a and retinoids. Semin Oncol 1983;10:290-293.
13. Grissom LE, Griffin GC, Mandell GA. Hypervitaminosis A as a complication of treatment for neuroblastoma. Pediatr Radiol 1996;26:200-202.
14. Michaelsson K, Lithell H, Vessby B, et al. Serum retinol levels and the risk of fracture. N Engl J Med 2003;348:287-294.
15. Michaelsson K, Lithell H, Vessby B, et al. Vitamin A, bones, and children. Pediatr Res 2003;53:881.
16. Barsony J, Prufer K. Vitamin D receptor and retinoid x receptor interactions in motion. Vitam Horm 2002;65:345-376.
17. Kohler JA, Imeson J, Ellershaw C, et al. A randomized trial of 13-cis retinoic acid in children with advanced neuroblastoma after high-dose therapy. Br J Cancer 2000;83:1124-1127.
18. Matthay KK, Reynolds CP. Is there a role for retinoids to treat minimal residual disease in neuroblastoma? Br J Cancer 2000;83:1121-1123.
19. Khan AA, Villablanca JG, Reynolds CP, et al. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Cancer Chemother Pharmacol 1996;39:34-41.